Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

TLR1 polyclonal antibody

 
ADI-905-725-100 100 µg 374.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:Toll-like receptor 1
 
Host:Rabbit
 
Immunogen:Synthetic peptide corresponding to the sequence near the N-terminus of human TLR1.
 
UniProt ID:Q15399
 
Species reactivity:Human, Mouse
 
Applications:IHC, WB
 
Recommended Dilutions/Conditions:Immunohistochemistry (10µg/ml)
Western Blot (1-2µg/ml)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Ion exchange purified.
 
Formulation:Liquid. In PBS containing 0.02% sodium azide.
 
Shipping:Blue Ice Not Frozen
 
Long Term Storage:+4°C
 
Scientific Background:The TLRs (Toll-like receptors) are a group of evolutionarily conserved pattern recognition molecules that play a key role in host defense during microbial infection by regulating both innate and adaptive immune responses. TLRs are type I transmembrane proteins with ectodomains containing interspersed leucine-rich repeat (LRR) motifs that are involved in the recognition of various microbial ligands.
 
TLR1 polyclonal antibody Immunohistochemistry
Immunohistochemistry analysis of TLR1 in mouse spleen tissue with TLR1 antibody at 10µg/ml.
TLR1 polyclonal antibody Western blot
Western blot analysis of TLR1 in mouse spleen lysate with TLR1 antibody at (A) 1, (B) 2, and (C) 4µg/ml.
Please mouse over
TLR1 polyclonal antibody Immunohistochemistry TLR1 polyclonal antibody Western blot

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
TLR
TLR1
By biological activity:
TLR Polyclonal antibody
TLR1 Polyclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,